Zimbabwe has declined a major American health deal worth $367m (£272m) over five years over the United States' demand for confidential data.
The decision came to light following a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "unbalanced".
A government spokesperson has since clarified that the United States was requesting biological samples for research and commercial purposes while refused to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further talks to find a deal acceptable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Background
This rejection comes after a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US after legal challenges were raised about the safety of Kenyans' medical information.
After resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
As per reports, Sixteen African countries have so far agreed to these new health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data for a long time, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Put simply, our nation would provide the raw materials for medical research with no certainty that the resulting innovations would be available to our citizens should a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending structures previously established through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as opposition to America," he added.
"We are open to continued discussions with our American counterparts on how future co-operation could be structured in a way that respects the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body said it recognised the government's concerns, but urged that negotiations need to persist since a large portion of the nation's Aids initiatives were funded by international support.
"Where specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it said.
The situation underscores the complex debate between receiving much-needed international aid and protecting a country's data in an increasingly interconnected world.